Page last updated: 2024-10-26

valproic acid and Anemia, Megaloblastic

valproic acid has been researched along with Anemia, Megaloblastic in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Anemia, Megaloblastic: A disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Güneş, H1
Acıpayam, C1
Akgüngör, F1
Kütükçü, M1

Other Studies

1 other study available for valproic acid and Anemia, Megaloblastic

ArticleYear
Leukemia-like megaloblastic anemia in an autistic child receiving risperidone and valproic acid.
    Pediatrics international : official journal of the Japan Pediatric Society, 2020, Volume: 62, Issue:10

    Topics: Anemia, Megaloblastic; Autistic Disorder; Child; Humans; Leukemia; Risperidone; Valproic Acid; Vitam

2020